Latest Dainippon Sumitomo Pharma Stories
OSAKA, Japan, Sept. 26, 2014 /PRNewswire/ -- Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc.
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
EPI-743 in phase 2B/3 development for Leigh syndrome MOUNTAIN VIEW, Calif., May 21, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced that the Japanese Ministry of Health,
First subject enrolled in pivotal clinical trial MOUNTAIN VIEW, Calif., March 10, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced the initiation of a phase 2B/3 study entitled,
MitoAction and UMDF have joined together to congratulate Edison Pharmaceuticals in their announcement last week of a nearly $4.3 billion strategic partnership with Dainippon Sumitomo Pharma Co.,
- A political dynamiter.